IXICO (LON:IXI) Shares Pass Above 200 Day Moving Average – Time to Sell?

IXICO plc (LON:IXI) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 8.75 ($0.11) and traded as high as GBX 12.50 ($0.16). IXICO shares last traded at GBX 11.75 ($0.15), with a volume of 30,000 shares traded.

IXICO Stock Up 2.2 %

The stock has a fifty day moving average of GBX 10.21 and a 200-day moving average of GBX 8.75. The firm has a market capitalization of £5.68 million, a price-to-earnings ratio of -293.75, a PEG ratio of -0.38 and a beta of 0.86. The company has a current ratio of 3.64, a quick ratio of 4.90 and a debt-to-equity ratio of 3.22.

Insider Buying and Selling

In other IXICO news, insider Grant Nash purchased 260,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The shares were purchased at an average cost of GBX 12 ($0.15) per share, with a total value of £31,200 ($39,664.38). Also, insider Mark Warne acquired 26,370 shares of the firm’s stock in a transaction on Thursday, October 10th. The shares were acquired at an average price of GBX 9 ($0.11) per share, with a total value of £2,373.30 ($3,017.16). 30.28% of the stock is currently owned by company insiders.

IXICO Company Profile

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.